Proteome Sciences (LON:PRM) Shares Up 12.4% – Here’s Why

Shares of Proteome Sciences plc (LON:PRM) shot up 12.4% on Monday . The company traded as high as GBX 2.08 and last traded at GBX 2.08. 100,788 shares changed hands during trading, a decline of 86% from the average session volume of 703,207 shares. The stock had previously closed at GBX 1.85.

Proteome Sciences Trading Up 12.4%

The business has a 50 day simple moving average of GBX 2.45 and a 200 day simple moving average of GBX 2.43. The company has a debt-to-equity ratio of -258.66, a current ratio of 0.20 and a quick ratio of 0.37. The company has a market cap of £7.30 million, a price-to-earnings ratio of -1.84 and a beta of 0.07.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.